BlueCrest Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,080
| Closed | -$783K | – | 291 |
|
|
2022
Q4 | $783K | Buy |
40,080
+2,145
| +6% | +$41.9K | 0.02% | 95 |
|
|
2022
Q3 | $793K | Buy |
37,935
+28,936
| +322% | +$605K | 0.02% | 111 |
|
|
2022
Q2 | $288K | Sell |
8,999
-59,911
| -87% | -$1.92M | 0.01% | 131 |
|
|
2022
Q1 | $2.81M | Sell |
68,910
-31,135
| -31% | -$1.27M | 0.09% | 98 |
|
|
2021
Q4 | $4.47M | Buy |
+100,045
| New | +$4.47M | 0.14% | 100 |
|
|
2021
Q2 | – | Sell |
-54,364
| Closed | -$2.49M | – | 588 |
|
|
2021
Q1 | $2.49M | Buy |
+54,364
| New | +$2.49M | 0.04% | 404 |
|
|
2020
Q4 | – | Sell |
-239,576
| Closed | -$10.6M | – | 401 |
|
|
2020
Q3 | $10.6M | Buy |
+239,576
| New | +$10.6M | 0.39% | 56 |
|
|
2020
Q2 | – | Sell |
-8,620
| Closed | -$355K | – | 266 |
|
|
2020
Q1 | $355K | Buy |
+8,620
| New | +$355K | 0.02% | 135 |
|